JD Bio Co., Ltd. Participates in the 2024 Clinical Cosmetic Regenerative Conference (CCR 2024) in London
Global medical beauty leading group JD Bio Co., Ltd. took part in the Clinical Cosmetic Regenerative Conference 2024 (CCR 2024), held from October 10 to 11, 2024, in London, UK. At this prominent event, the company showcased its CE-certified OneFill™ brand, along with new products such as TEOFILL™, CPNP-certified RICHESSE™, and Exo'One™, representing a diverse range of its offerings.
The CCR 2024 is the UK’s largest beauty exhibition, featuring cutting-edge technologies in medical aesthetics, including non-invasive techniques, surgical equipment, laser treatments, botulinum toxin, fillers, treatment systems, training, and consulting.
JD Bio Co., Ltd. is committed to leveraging its outstanding product capabilities—represented by OneFill™, RICHESSE™, TEOFILL™, and Exo'One™ to develop a differentiated localization strategy aimed at growing its presence in the UK and European markets. Following the exhibition, the company plans to participate in various international events, continuously advancing toward its goal of becoming a leading group in the global medical beauty sector.
Global medical beauty leading group JD Bio Co., Ltd. took part in the Clinical Cosmetic Regenerative Conference 2024 (CCR 2024), held from October 10 to 11, 2024, in London, UK. At this prominent event, the company showcased its CE-certified OneFill™ brand, along with new products such as TEOFILL™, CPNP-certified RICHESSE™, and Exo'One™, representing a diverse range of its offerings.
The CCR 2024 is the UK’s largest beauty exhibition, featuring cutting-edge technologies in medical aesthetics, including non-invasive techniques, surgical equipment, laser treatments, botulinum toxin, fillers, treatment systems, training, and consulting.
JD Bio Co., Ltd. is committed to leveraging its outstanding product capabilities—represented by OneFill™, RICHESSE™, TEOFILL™, and Exo'One™ to develop a differentiated localization strategy aimed at growing its presence in the UK and European markets. Following the exhibition, the company plans to participate in various international events, continuously advancing toward its goal of becoming a leading group in the global medical beauty sector.
